• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

FDA clears Cerus Endovascular 027 microcatheters

March 23, 2022 By Danielle Kirsh

cerus-endovascularCerus Endovascular this week announced the FDA 510(k) clearance of its 027 microcatheters.

Fremont, California-based Cerus Endocascular’s new microcatheters are available in two lengths. The company expects to submit for CE mark approval under the EU new Medical Devices Regulation later this year.

A limited market release of the 027 microcatheters in the U.S. is expected to begin in the second quarter of 2022, with Cerus Endovascular’s 021 microcatheters platform to follow.

“Our focus on continually meeting the demands of the clinical and physician communities, including interventional radiologists, with timely, value-added products, is evidenced by this latest FDA approval for the 027 micro-catheters, for which sales will commence shortly, both domestically and internationally,” Cerus Endovascular President Stephen Griffin said in a news release.

With the announcement of the clearance, the company said it is expanding the size offerings of its Contour Neurovascular System platform. The new sizes, 3 mm, 18 mm and 22 mm, are currently in development and will allow for the treatment of aneurysms up to 18 mm in diameter.

“The continued expansion of our portfolio and the increased market penetration are key elements of our ongoing commercialization strategy,” Cerus Endovascular Chair Sam Milstein said in the news release. “The company’s commercial footprint now extends to over 330 clinical centers, worldwide, and will shortly be expanding further into Asia and launching in Central and South America. Enrollment in the Cerus Endovascular IDE trial in the United States continues as scheduled.”

Filed Under: Catheters Tagged With: Cerus Endovascular

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS